You just read:

The Leukemia & Lymphoma Society and Johns Hopkins University School of Medicine to Collaborate on a Phase II Clinical Trial to Advance Innovative Immunotherapy for Multiple Myeloma Patients

News provided by

The Leukemia & Lymphoma Society

Jul 01, 2013, 12:11 ET